Microaspiration as a cause for respiratory disease in children
Microaspiration as a cause for respiratory disease in children
批准号:
8080216
负责人:
Rachel L Rosen
金额:
$8.59万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2013-12-31
关键词:
AddressAgeAspirate substanceAsthmaBacteriaBile AcidsBile fluidBiological AssayBostonBronchial LavagesBronchoscopyChildChildhoodChronicCommitCoughingDataDiagnosisDiagnosticDiseaseDistalEndoscopyEndotoxinsEsophageal TissueEsophagusEvaluationFrequenciesGastroesophageal reflux diseaseGastrointestinal tract structureGoalsGoldInflammatoryInflammatory ResponseLiquid substanceLungLung InflammationLung diseasesMeasurementMeasuresMentorsMicrobeMonitorMorbidity - disease ratePathologicPatientsPatternPediatric HospitalsPepsin APneumoniaPrincipal InvestigatorPulmonary aspiration of gastric contentsRecruitment ActivityRefluxResearch InfrastructureResearch PersonnelRoleStomachTestingTimecytokineelectric impedancehypopharynxinsightnovel markerpublic health relevancetool
中文摘要
描述(由申请人提供):
超过12%的儿童在童年时期被诊断患有哮喘,高达73%的哮喘儿童通过pH测试有病理性反流的证据。本研究将确定反流内容物的微抽吸在哮喘和咳嗽发生中的作用。我们将招募1至21岁的儿童,他们正在接受支气管镜检查、内窥镜检查和多通道腔内阻抗测试(pH-MII),以评估哮喘和咳嗽。使用支气管灌洗和胃液,我们将确定:(1)全柱反流是否导致胃内容物吸入肺;(2)胃内容物吸入是否导致肺部炎症;(3)肺中的细菌组成是否与反流相关肺部疾病儿童胃液中的细菌组成相似。
首先,我们将确定肺部疾病患者肺部胆汁的频率。胆汁应该只存在于胃肠道中,所以它在肺中的存在将表明微吸入。我们将比较肺中有胆汁和无胆汁患者的全柱胃食管反流量(测量的pH-MII),以确定全柱反流是否是反流相关肺部疾病的指标。
其次,我们将确定肺内有胆汁的患者是否比肺内无胆汁的患者具有更高的NF-β B活化和不同的细胞因子模式。胆汁引起食管组织的炎症反应,我们假设肺中的胆汁也会引起类似的炎症反应。
第三,我们将确定在胃液和肺液之间存在匹配的细菌种类的患者的比例;我们假设细菌栖息在胃中,并且这些细菌可以被回流和抽吸,从而导致胃液和肺液之间的细菌种类匹配。此外,我们预期,在具有匹配细菌种类的患者中,与没有匹配种类的患者相比,将存在更高水平的NF-β B活性和不同的细胞因子模式。
本研究的结果将用于更准确地确定哪些患者患有反流相关肺部疾病,因此可以从反流治疗中获益。
公共卫生相关性:
本研究将通过测量返流相关肺部疾病的新标志物(包括胆汁和细菌成分)来确定微抽吸在哮喘和咳嗽发生中的作用。研究结果将使临床医生能够更好地确定哪些呼吸系统疾病患者将从反流治疗中受益。
英文摘要
DESCRIPTION (provided by applicant):
More than 12% of children are diagnosed with asthma over the course of their childhood and up to 73% of children with asthma have evidence of pathologic reflux by pH testing. This study will determine the role of microaspiration of refluxed contents in the genesis of asthma and cough. We will recruit children ages 1 to 21 years who are undergoing bronchoscopy, endoscopy, and multichannel intraluminal impedance testing (pH-MII) for the evaluation of asthma and cough. Using bronchial lavage and gastric fluid, we will determine: (1) if full column reflux results in aspiration of gastric contents into the lung; (2) if aspiration of gastric contents results in lung inflammation; and (3) if the bacterial composition in the lungs mimics the bacterial composition in gastric fluid in children with reflux-related pulmonary disease.
First, we will determine the frequency of bile in the lungs of patients with pulmonary disease. Bile should only present in the gastrointestinal tract so its presence in the lungs would indicate microaspiration. We will compare the amount of full column gastroesophageal reflux, measured pH-MII, in those patients with and without bile in the lungs to determine if full column reflux is an indicator of reflux-related lung disease.
Second, we will determine if patients with bile in the lung have higher NF-(B activation and different cytokine patterns than patients without bile in the lung. Bile provokes an inflammatory response in esophageal tissue and we hypothesize that bile in the lung will result in a similar inflammatory response.
Third, we will determine the proportion of patients in whom there are matching bacterial species between the gastric and lung fluid; we hypothesize that bacteria inhabit the stomach and that these bacteria can be refluxed and aspirated resulting in matching species of bacteria between gastric and lung fluid. Additionally, we anticipate that, in patients with matching bacterial species, there will be higher levels of NF-(B activity and different cytokine patterns than those patients without matching species.
The results of this study will be used to determine more accurately which patients have reflux-related lung disease and, therefore, could benefit from reflux therapy.
PUBLIC HEALTH RELEVANCE:
This study will determine the role of microaspiration in the genesis of asthma and cough through the measurement of new markers of reflux-related lung disease including bile and bacterial composition. The results of the study will allow clinicians to better determine which patients with respiratory disease will benefit from reflux therapy.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
The impact of upper gastrointestinal dysmotility on aspiration-associated aerodigestive disorders in children
-
批准号:10684831
-
项目类别:
-
资助金额:$55.55万
-
财政年份:2015
-
负责人:Rachel L Rosen
-
依托单位:
Microaspiration as a cause for respiratory disease in children
-
批准号:7977213
-
项目类别:
-
资助金额:$8.59万
-
财政年份:2010
-
负责人:Rachel L Rosen
-
依托单位:
Impact of non-acid reflux on respiratory diseases in children
-
批准号:8018091
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2007
-
负责人:Rachel L Rosen
-
依托单位:
Impact of non-acid reflux on respiratory diseases in children
-
批准号:7761221
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2007
-
负责人:Rachel L Rosen
-
依托单位:
Impact/non-acid reflux/respiratory diseases/children
-
批准号:7342470
-
项目类别:
-
资助金额:$12.88万
-
财政年份:2007
-
负责人:Rachel L Rosen
-
依托单位:
Impact of non-acid reflux on respiratory diseases in children
-
批准号:7564665
-
项目类别:
-
资助金额:$12.88万
-
财政年份:2007
-
负责人:Rachel L Rosen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: